LD-2 disclosure · 2nd Quarter - Report
BRIDGEBIO PHARMA
Client
- Name
- BRIDGEBIO PHARMA
- Description
- Biopharmaceutical manufacturer.
- Location
- California · United States of America
Registrant
- Description
- ​Government affairs and consulting firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issuePharmacy
Issues related to pharmaceutical manufacturing, drug pricing, and orphan drugs. Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to FDA regulation of pharmaceuticals.
LobbyistsMONICA POPP · HAZEN CLAY MARSHALL
Covered position (MONICA POPP): Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint
Covered position (HAZEN CLAY MARSHALL): Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)